8/22/2024CDE Solicits Public Comments on the Guidelines for Clinical Virologica...

8/22/2024Jacobio Terminates Clinical Development of JAB-3068

8/22/2024Everest Medicines Announces Initiation of Clinical Trial for Personali...

8/21/2024Six Drug Cos Sanctioned for Bid-Rigging in China’s Centralized Drug P...

8/21/2024Astellas Executive Indicted in China after Detention

8/21/2024GenFleet Wins Chinese Approval of Its KRAS G12C Inhibitor

8/20/2024AstraZeneca Gains Chinese Approval of New Asthma Drug

8/20/2024U.S. Lawmakers Call on the FDA to Investigate Clinical Trials Conducte...

8/20/2024TYK Medicines Raises $74M thru IPO to Fund Core Asset Development

8/20/2024Adcendo Enters $1B Biobuck Deal for Multitude's Anti-TF ADC

8/20/2024Merck Adjusts ADC Partnership with Kelun-Biotech, Takes Up One Option ...

8/19/2024FDA Lifts Partial Hold on BioNTech-MediLink ADC Study

8/19/2024Aurobindo to Begin Production in China Soon

8/19/2024Germany Warns of Potential Drug Shortages Due to China's Espionage Law

8/19/2024NMPA Restores Import, Sales and Use of UCB's Keppra

8/19/2024Astellas Secures Chinese Approval of Nectin-4 ADC Drug

8/16/2024Recent Official and Executive Moves

8/16/2024DualityBio Initiates Phase 1 Trial of ADC drug DB-1419 for Various Sol...

8/16/2024Huadong Secures Asia Rights to Two South Korean Autoimmune Disease Dru...

8/15/2024China Introduces Guidelines to Encourage Development of 'Digital, Smar...

8/15/2024SAMR Releases Draft Pharma Anti-monopoly Guidelines

8/15/2024Akeso's sNDA for Ivonescimab (PD-1/VEGF) Granted Priority Review in Ch...

8/14/2024GSK Launches Phase 3 Trial for RSV Vaccine in China

8/14/2024Apollomics Announces Positive Preliminary Data of Vebreltinib

8/13/2024AstraZeneca and Daiichi Sankyo Secure Third Approval For Enhertu in Ch...

8/13/2024Junshi's sNDA for Toripalimab as First-Line Treatment of Unresectable/...

8/13/2024MNC Pharma Companies in China Return to Growth after Years of VBP Turb...

8/13/2024OcuMension Acquires China Rights to Alcon Eye Drops with 16.7% Equity ...

8/12/2024Genor License ex-China Rights for CD20/CD3 Bispecific to TRC 2004

8/9/2024Recent Executive Moves

Page:47/52 Total number of articles:1550: [First][<<] [45] [46] [47] [48] [49] [>>] [End]